Post-marketing safety surveillance of voclosporin: an observational, pharmacovigilance study leveraging faers database study on the safety of voclosporin. (PubMed, Front Pharmacol) - Jun 3, 2025 - "Nearly one-third of the adverse events occurred within the first month after voclosporin initiation, with a median onset time of 99 days. This study clarified the characteristics of voclosporin-related adverse drug reactions, providing strong support for clinical monitoring and risk identification of voclosporin."
Adverse events • Journal • P4 data • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Respiratory Diseases
|
|
Leping Shao; Xuyan Liu; Yanhua Lang; Yuxuan Wang; Zhi Wang
|